Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Adds comments from FDA news conference)By Ankur Banerjee and Michael ErmanOct 20 (Reuters) - The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said Ame...
Read more
(Sharecast News) - Novavax's manufacturing problems may be more serious than previously thought and could hamper global efforts to fight Covid-19.
Read moreLONDON, Oct 20 (Reuters) - A subvariant of Delta that is growing in England is being monitored but is not likely to change the COVID-19 picture, Oxford Vaccine Group chief Andrew Pollard said on Wednesday.The subvariant, designated as AY.4.2 in Br...
Read more(Adds comment)By Guy FaulconbridgeLONDON, Oct 20 (Reuters) - Nearly half of the 100 biggest companies listed on Britain's FTSE Index have no net-zero target at all and just 23 have a scientifically approved plan, according to ESG investment resear...
Read moreLONDON, Oct 20 (Reuters) - Nearly half of the 100 biggest companies listed on Britain's FTSE Index have no net-zero target at all and just 23 have a scientifically approved plan, according to ESG investment research and asset manager Arabesque.Br...
Read more(Repeats to wider subscription base)NEW DELHI, Oct 19 (Reuters) - A "sizeable number" of people in India have not taken their second COVID-19 vaccine dose by the due date despite adequate supplies, the health ministry said on Tuesday, as new infec...
Read moreNEW DELHI, Oct 19 (Reuters) - A "sizeable number" of people in India have not taken their second COVID-19 vaccine dose by the due date despite adequate supplies, the health ministry said on Tuesday, as new infections fell to their lowest since ear...
Read more
LONDON BROKER RATINGS: Upgrades for Pearson; Berenberg cuts IAG, Wizz
Read more(Sharecast News) - A Covid-19 vaccine being developed by Valneva performed better than AstraZeneca's jab in trials, the French biotech announced on Monday, sending its shares soaring.
Read more(adds context)By Francesco GuarascioBRUSSELS, Oct 18 (Reuters) - More than a billion COVID-19 vaccines produced in the European Union have been exported since December 2020, making the bloc the biggest exporter of the shots, European Commission he...
Read moreTOP NEWS: AstraZeneca urges shareholders to veto TRC mini-tender offer
Read moreLONDON BRIEFING: Playtech accepts GBP2 billion Australian takeover
Read more(Sharecast News) - Pharmaceutical giant AstraZeneca on Monday recommended shareholders of its American depositary shares reject a $115m 'mini-tender' offer from TRC Capital Investment, due to a low bid price.
Read more* Shares jump over 30% after Phase III interim results for VLA2001* Study shows similar efficacy to AstraZeneca, less adverse effects* Targets UK approval by year-end, EU approval by next March (Updates throughout with company comment from call, s...
Read more(Adds details, background)By David ShepardsonWASHINGTON, Oct 15 (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) said late on Friday that it will accept mixed-dose coronavirus vaccines from international travelers, a boost to ...
Read more
Last checked at